Jubilant IngreviaBOM:543271 -0.36%81 EBITDA Margin % is 14.74% as of Mar. 2026, which is 8% above its 10-year median of 13.59. GuruFocus rates BOM:543271 with a GF Score™ of 81/100 and a GF Value™ of ₹698.96 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,579 Chemicals companies, Jubilant Ingrevia ranks better than 65.36% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Jubilant Ingrevia's EBITDA for the
three
months ended in Mar. 2026 was ₹1,719 Mil. Jubilant Ingrevia's Revenue for the
three
months ended in Mar. 2026 was ₹11,661 Mil. Therefore, Jubilant Ingrevia's EBITDA margin for the quarter that ended in Mar. 2026 was 14.74%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Jubilant Ingrevia EBITDA Margin % Related Terms
Jubilant Ingrevia EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Jubilant Ingrevia's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543271 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Jubilant Ingrevia's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jubilant Ingrevia EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Jubilant Ingrevia's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Jubilant Ingrevia's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jubilant Ingrevia (BOM:543271) has a EBITDA Margin % of 14.74% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jubilant Ingrevia and its competitors. This is near median its historical median of 13.59. Over the past decade, Jubilant Ingrevia's EBITDA Margin % has ranged from 11.12 to 17.49. According to the industry distribution chart, Jubilant Ingrevia ranks #547 out of 1579 companies in the Chemicals industry, placing it in the top 34.6%.
Is Jubilant Ingrevia's EBITDA Margin % too high?
Jubilant Ingrevia's current EBITDA Margin % of 14.74% is near median its 10-year median of 13.59. Over the past 10 years, this metric has ranged from a low of 11.12 to a high of 17.49. The Chemicals industry median EBITDA Margin % is 9.63. Jubilant Ingrevia's value of 14.74% is 53.1% above this industry median. Based on the distribution chart, Jubilant Ingrevia ranks #547 out of 1579 companies in the Chemicals industry, which is above the industry midpoint. Overall, Jubilant Ingrevia has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Jubilant Ingrevia ranks #547 out of 1579 companies for EBITDA Margin %. This puts Jubilant Ingrevia in the upper half of its industry. The industry median EBITDA Margin % is 9.63. Jubilant Ingrevia's value of 14.74% is 53.1% above this benchmark. Historically, Jubilant Ingrevia's own EBITDA Margin % has ranged from 11.12 to 17.49 over the past decade. While the company's 10-year median is 13.59 vs. the industry median of 9.63, Jubilant Ingrevia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jubilant Ingrevia's current EBITDA Margin % of 14.74% is 53.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jubilant Ingrevia and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jubilant Ingrevia's current EBITDA Margin % is 14.74%, which is near median its own 10-year median of 13.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹698.96, compared to a current price of ₹608.75 — trading 12.9% below its estimated fair value. The current EBITDA Margin % is 14.74%, which is near median its 10-year median of 13.59 and 53.1% above the Chemicals industry median of 9.63. Jubilant Ingrevia's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current EBITDA Margin % is 14.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?
Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued.
The current stock price of ₹608.75 is trading 12.9% below its estimated GF Value™ of ₹698.96.
GuruFocus considers Jubilant Ingrevia to be Modestly Undervalued.
Key valuation signals for BOM:543271:
EBITDA Margin %: 14.74% (near median its 10-year median of 13.59)
GF Value™: ₹698.96 vs. price of ₹608.75 (12.9% below fair value)
Industry Position: 53.1% above the Chemicals median (#547 of 1579)
No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
81GF Score
Get the complete analysis for BOM:543271
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543271 has been successfully added to your 
